Maplebear
CART
45.21
-0.26
-0.57%
Maplebear
US · CART
#1429 by market cap
Listed 2023
45.21
-0.26
-0.57%
Live - 5344 symbols - heartbeat 79s ago
· 2026-10-07 20:02
After-hours
45.17
-0.09%
- Market cap
- 10.73B
- P/E (TTM)i
- 24.70
- P/Bi
- 4.62
- EPSi
- 1.60
- Div yieldi
- 0.00%
- 52W posi
- 63%
Reader sentiment
Are you bullish or bearish on CART?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.68, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 6 years
Latest year +10.78% YoY
Margins
- Gross margin
- 73.70%
- Operating margin
- 13.31%
- Net margin
- 11.71%
Key ratios & quality
- PEG ratioi
- 16.94
- Altman Z-Scorei
- 5.68
PEG uses trailing P/E against the 3-year net income growth rate (1.46%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 1.48B | 1.83B | 2.55B | 3.04B | 3.38B | 3.74B |
| Gross profit | 879.00M | 1.23B | 1.83B | 2.28B | 2.54B | 2.76B |
| Selling & admin expenses | 436.00M | 682.00M | 999.00M | 1.76B | 1.17B | 1.34B |
| Research & development | 194.00M | 368.00M | 518.00M | 2.31B | 604.00M | 650.00M |
| Operating profit | -75.00M | -86.00M | 62.00M | -2.14B | 489.00M | 498.00M |
| Pretax profit | -70.00M | -72.00M | 71.00M | -2.06B | 552.00M | 556.00M |
| Tax | 0 | 1.00M | -357.00M | -439.00M | 95.00M | 109.00M |
| Net profit | -70.00M | -73.00M | 428.00M | -1.62B | 457.00M | 447.00M |
| Basic EPS | 0 | 0 | 0 | -12 | 2 | 2 |
| Diluted EPS | -0.25 | -0.26 | 0.28 | -12.43 | 1.58 | 1.60 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 897.00M | 914.00M | 939.00M | 992.00M | 1.02B | 1.04B |
| Gross profit | 671.00M | 678.00M | 692.00M | 717.00M | 738.00M | 751.00M |
| Selling & admin expenses | 342.00M | 323.00M | 293.00M | 377.00M | 318.00M | 331.00M |
| Research & development | 144.00M | 166.00M | 169.00M | 171.00M | 164.00M | 202.00M |
| Operating profit | 110.00M | 123.00M | 168.00M | 98.00M | 182.00M | 144.00M |
| Pretax profit | 124.00M | 142.00M | 181.00M | 109.00M | 188.00M | 147.00M |
| Tax | 18.00M | 26.00M | 37.00M | 28.00M | 44.00M | 36.00M |
| Net profit | 106.00M | 116.00M | 144.00M | 81.00M | 144.00M | 111.00M |
| Basic EPS | 0 | 0 | 1 | 0 | 1 | 0 |
| Diluted EPS | 0.37 | 0.41 | 0.51 | 0.30 | 0.57 | 0.45 |
Balance sheet
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total current assets | -- | 2.40B | 2.74B | 3.31B | 2.70B | 2.20B |
| Cash & ST investments | -- | 1.49B | 1.71B | 2.19B | 1.37B | 687.00M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | -- | 2.96B | 3.67B | 4.73B | 4.12B | 3.69B |
| Total current liabilities | -- | 592.00M | 795.00M | 733.00M | 798.00M | 917.00M |
| Short-term debt | -- | 11.00M | 13.00M | 13.00M | 13.00M | 3.00M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | -- | 3,534,000,000.00 | 3,733,000,000.00 | 977,000,000.00 | 1,022,000,000.00 | 1,169,000,000.00 |
| Total equity | -- | -573.00M | -64.00M | 3.75B | 3.09B | 2.52B |
| Retained earnings | -- | -1.41B | -977.00M | -2.64B | -3.59B | -4.49B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.87B | 2.89B | 3.03B | 2.20B | 2.09B | 2.12B |
| Cash & ST investments | 1.63B | 1.60B | 1.73B | 687.00M | 690.00M | 850.00M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 4.29B | 4.43B | 4.54B | 3.69B | 3.54B | 3.51B |
| Total current liabilities | 887.00M | 871.00M | 832.00M | 917.00M | 885.00M | 929.00M |
| Short-term debt | 13.00M | 3.00M | 3.00M | 3.00M | 2.00M | 3.00M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 1,116,000,000.00 | 1,133,000,000.00 | 1,082,000,000.00 | 1,169,000,000.00 | 1,140,000,000.00 | 1,187,000,000.00 |
| Total equity | 3.18B | 3.30B | 3.46B | 2.52B | 2.40B | 2.32B |
| Retained earnings | -3.57B | -3.57B | -3.49B | -4.49B | -4.74B | -4.96B |
Cash flow
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -91.00M | -204.00M | 277.00M | 586.00M | 687.00M | 971.00M |
| Depreciation & amortization | 20.00M | 27.00M | 47.00M | 57.00M | 67.00M | 99.00M |
| Free cash flow | -98.00M | -226.00M | 253.00M | 532.00M | 623.00M | 910.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 125.00M | 0 | 365.00M | -1.40B | -1.39B |
| Ending cash balance | 1.24B | 1.17B | 1.60B | 2.29B | 1.45B | 827.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 298.00M | 203.00M | 287.00M | 183.00M | 268.00M | 494.00M |
| Depreciation & amortization | 22.00M | 23.00M | 28.00M | 26.00M | 30.00M | 34.00M |
| Free cash flow | 280.00M | 187.00M | 272.00M | 171.00M | 252.00M | 481.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -89.00M | -121.00M | -62.00M | -1.11B | -359.00M | -324.00M |
| Ending cash balance | 1.70B | 1.63B | 1.83B | 827.00M | 758.00M | 874.00M |
Returns & efficiency
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -88.12 | 13.09 | 15.61 |
| ROA %i | -- | -2.47 | 2.32 | -38.69 | 10.13 | 11.23 |
| ROIC %i | -- | -- | -- | -89.42 | 11.39 | 13.83 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -5.08 | -4.69 | 2.43 | -70.41 | 14.48 | 13.31 |
| FCF / sales %i | -- | -- | 9.84 | 17.42 | 18.44 | 24.32 |
| Current ratioi | -- | 4.05 | 3.45 | 4.51 | 3.38 | 2.40 |
| Quick ratioi | -- | 3.93 | 3.22 | 4.15 | 2.99 | 1.98 |
| Debt / assetsi | -- | 1.82 | 1.34 | 0.85 | 0.63 | 0.98 |
| LT debt / equityi | -- | -- | -- | 0.72 | 0.42 | 1.31 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 27.23 | 22.58 | 13.62 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | 1.46 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | 53.22 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 13.42 | 15.14 | 15.96 | 15.61 | 17.09 | 16.75 |
| ROA %i | 10.11 | 11.35 | 11.93 | 11.23 | 12.16 | 11.86 |
| ROIC %i | 11.76 | 13.52 | 14.30 | 13.83 | 15.56 | 15.49 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 13.17 | 14.89 | 15.28 | 13.31 | 14.75 | 14.75 |
| FCF / sales %i | 23.50 | 21.97 | 24.22 | 24.32 | 22.83 | 29.45 |
| Current ratioi | 3.24 | 3.32 | 3.64 | 2.40 | 2.36 | 2.28 |
| Quick ratioi | 2.94 | 3.03 | 3.33 | 1.98 | 2.02 | 1.97 |
| Debt / assetsi | 0.51 | 0.83 | 0.82 | 0.98 | 0.96 | 0.97 |
| LT debt / equityi | 0.28 | 1.03 | 0.98 | 1.31 | 1.34 | 1.33 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-07 20:02:39 · For reference only, not investment advice and not tailored to your situation.